MDI- Weight loss diagram

Description

Visual approach to patient weight loss
Annie Nguyen
Mind Map by Annie Nguyen, updated more than 1 year ago
Annie Nguyen
Created by Annie Nguyen over 7 years ago
29
0

Resource summary

MDI- Weight loss diagram
  1. BMI: Normal
    1. Online Wellness System
      1. MDI Supplements
        1. Food Journal
          1. Starter Book
          2. BMI: Overweight ( 25-29)/ Obese (>30)
            1. Annual Tests/ BaseLine results 1. Basic Labs 2. ANS 3. ECHO
              1. Obesity Medications
                1. Anxiety /Depression
                  1. Contrave

                    Annotations:

                    • Contrave naltrexone/ bupropion hydrochloride   Adult Dosing . Dosage forms: 8 ER/90 ER obesity, long-term tx [2 tabs PO bid] Start: 1 tab PO qam x1wk, then 1 tab PO bid x1wk, then 2 tabs PO qam and 1 tab PO qpm x1wk; Max: 4 tabs/day; Info: D/C if wt loss <5% after 12wk on max dose; do not cut/crush/chew tab; avoid admin. w/ high fat meal
                    1. Cardiac Neutral: Red
                  2. Migraines/ Headaches
                    1. Qsymia: Phentermine/Topiramate

                      Annotations:

                      • Qsymia phentermine hydrochloride/ topiramate Adult Dosing . Dosage forms: 3.75/23 ER,7.5/46 ER,11.25/69 ER,15/92 ER obesity, long-term tx [7.5 mg/46 mg or 15 mg/92 mg PO qam] Start: 3.75 mg/23 mg PO qam x14 days, then incr. to 7.5 mg/46 mg PO qam; Max: 15 mg/92 mg/day; Info: if wt loss <3% after 12wk, consider D/C or incr. dose to 11.25 mg/69 mg PO qam x14 days, then 15 mg/92 mg PO qam; D/C if wt loss <5% after 12wk on max dose; taper max dose to qod >1wk to D/C Restricted Distribution in US [1-888-998-4887 or http://www.QsymiaREMS.com for more info]
                    2. Overeating
                      1. Phentermine

                        Annotations:

                        • phentermine hydrochloride obesity, short-term tx [15-37.5 mg PO qam]Max: 37.5 mg/day; Info: give before or 1-2h after breakfast; may divide dose bid; tabs may be split, but do not cut/crush/chew caps; D/C when tolerance occurs; taper dose gradually to D/C if prolonged, high dose use
                        1. Binge Eating Disorder

                          Annotations:

                          • Binge eating disorder (BED) is an eating disorder characterized by recurrent episodes of eating large quantities of food (often very quickly and to the point of discomfort); a feeling of a loss of control during the binge; experiencing shame, distress or guilt afterwards; and not regularly using unhealthy compensatory measures (e.g., purging) to counter the binge eating. Binge eating disorder is a severe, life-threatening and treatable eating disorder. Common aspects of BED include functional impairment, suicide risk and a high frequency of co-occurring psychiatric disorders. 
                          1. Vyvanse

                            Annotations:

                            • Vyvanse lisdexamfetamine   Adult Dosing .  Dosage forms: 10,20,30,40,50,60,70 ADHD [30-70 mg PO qam] Start: 30 mg PO qam, may incr. by 10-20 mg/day qwk; Max: 70 mg/day; Info: duration 10-14h; use lowest effective dose; periodically reassess need for tx; taper dose gradually to D/C if prolonged, high dose use; may open cap
                          2. Lorcaserin

                            Annotations:

                            • Qsymia phentermine hydrochloride/ topiramate   Adult Dosing . Dosage forms: 3.75/23 ER,7.5/46 ER,11.25/69 ER,15/92 ER   obesity, long-term tx [7.5 mg/46 mg or 15 mg/92 mg PO qam] Start: 3.75 mg/23 mg PO qam x14 days, then incr. to 7.5 mg/46 mg PO qam; Max: 15 mg/92 mg/day; Info: if wt loss <3% after 12wk, consider D/C or incr. dose to 11.25 mg/69 mg PO qam x14 days, then 15 mg/92 mg PO qam; D/C if wt loss <5% after 12wk on max dose; taper max dose to qod >1wk to D/C Restricted Distribution in US [1-888-998-4887 or http://www.QsymiaREMS.com for more info]
                            1. Cardiac Neutral: Red
                          3. ADHD
                            1. Evekeo

                              Annotations:

                              • Evekeo amphetamine  Adult Dosing . Dosage forms: 5,10 ADHD [5-40 mg/day PO divided qd-tid] Start: 5 mg PO qam or bid, incr. by 5 mg/day qwk; Info: give divided doses at 4-6h intervals; doses >40 mg/day rarely more effective; taper dose gradually to D/C if prolonged, high dose useTreating attention deficit hyperactivity disorder (ADHD). It is also used to treat a type of sleep disorder (narcolepsy). It is also used on short-term basis (a few weeks) in combination with other treatments to treat obesity. It may also be used for other conditions as determined by your doctor.Evekeo is a central nervous system stimulant. Exactly how it works is not known. It affects certain chemicals in the brain, which may help to improve attention span and behavior.
                              1. Vyvanse

                                Annotations:

                                • Vyvanse lisdexamfetamine Adult Dosing . Dosage forms: 10,20,30,40,50,60,70 ADHD [30-70 mg PO qam] Start: 30 mg PO qam, may incr. by 10-20 mg/day qwk; Max: 70 mg/day; Info: duration 10-14h; use lowest effective dose; periodically reassess need for tx; taper dose gradually to D/C if prolonged, high dose use; may open cap
                              2. Diabetes
                                1. AVOID: BELVIQ
                                  1. Saxenda/ Victoza

                                    Annotations:

                                    • Saxenda liraglutide Adult Dosing . Dosage forms: SC obesity, long-term tx [3 mg SC qd] Start: 0.6 mg SC qd x1wk, then may incr. dose by 0.6 mg/day qwk; Max: 3 mg/day; Info: retitrate from 0.6 mg SC qd if tx interrupted for >3 daysSaxenda (liraglutide) is similar to a hormone that occurs naturally in the body and helps control blood sugar, insulin levels, and digestion.Saxenda is an injectable prescription medicine that may help some obese adults or overweight adults who also have weight related medical problems lose weight and keep the weight off. It is used together with diet and exercise.Saxenda is not a weight-loss medicine or appetite suppressant.
                                    1. Cardiac Neutral: Red
                            Show full summary Hide full summary

                            Similar

                            Epidemiology
                            Danielle Richardson
                            History of Medicine: Ancient Ideas
                            James McConnell
                            Epithelial tissue
                            Morgan Morgan
                            4. The Skeletal System - bones of the skull
                            t.whittingham
                            Neuro anatomy
                            James Murdoch
                            The Endocrine System
                            DrABC
                            Respiratory anatomy
                            James Murdoch
                            Medical Terminology
                            khachoe_pema
                            Diabetes - pathophysiology
                            Morgan Morgan
                            Neuro system
                            James Murdoch